Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S4LL
|
||||
Former ID |
DIB013979
|
||||
Drug Name |
Sanfetrinem
|
||||
Synonyms |
Sanfetrinem sodium; GV-104326; GV-104326B; GV-104326X; GV-326; LK-176
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Discontinued in Phase 3 | [545093] | ||
Company |
Glaxo Wellcome plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H18NO5-
|
||||
Canonical SMILES |
N12C(=C3[C@@H]([C@@H]2[C@H](C1=O)[C@H](O)C)CCC[C@@H]3OC<br />)C(=O)O
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Bacterial penicillin binding protein | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.